(Q33487992)
Statements
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma (English)
D. G. Maloney
T. M. Liles
D. K. Czerwinski
C. Waldichuk
J. Rosenberg
1 October 1994